Document is current

Article History

Received: 3 November 2022

Accepted: 12 October 2023

First Online: 28 November 2023

Declarations

:

: The Biomedical Ethics Review Committee at West China Hospital of Sichuan University accepted the research protocol (2022 Audit [596]), which was then registered in the Chinese Clinical Trials Registry. Any amendments to the protocol will be discussed among all investigators and reported to the ethics committees responsible for approval of the trial. Written informed consent will be obtained from all study participants. Trained physicians at each center are responsible for recruiting patients and obtaining the necessary informed consent. All participants are advised that participation in this research is entirely voluntary and that they can withdraw at any time. If a patient is considering withdrawal from the study, the sponsor and a researcher will communicate with the patient at that time to fully understand the patient’s reasons for wanting to withdraw, assist them to resolve any difficulties, and attempt to persuade the patient to complete the study. If the patient’s final decision is to withdraw, the researchers will measure all relevant indicators at the time of the exit visit.

: Copies of the informed consent forms are available upon request.

: The authors declare that they have no competing interests.